Maternal smoking and fetal sex significantly affect metabolic enzyme expression in the human fetal liver

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 9, 2011, Pages 2851-2860

  O'Shaughnessy, Peter J ^a   Monteiro, Ana ^a   Bhattacharya, Siladitya ^b   Fowler, Paul A ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; CYTOCHROME P450 1A2; CYTOCHROME P450 2A1; CYTOCHROME P450 2B6; CYTOCHROME P450 2R1; CYTOCHROME P450 3A7; DIMETHYLANILINE MONOOXYGENASE; EPOXIDE HYDROLASE; GAMMA GLUTAMYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A9; GLUTAREDOXIN; GLUTAREDOXIN 2; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; FETUS LIVER; HOUSEKEEPING GENE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MATERNAL SMOKING; NORMAL HUMAN; OBSERVATIONAL STUDY; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA EXTRACTION; SECOND TRIMESTER PREGNANCY; SEX DIFFERENCE; WESTERN BLOTTING;

FEMALE; GENE EXPRESSION; HUMANS; LIVER; MALE; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SEX FACTORS; SMOKING;

EID: 80052520334     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1437     Document Type: Article

References (55)

1. Wigle D.T., Arbuckle T.E., Walker M., Wade M.G., Liu S., Krewski D. 2007 Environmental hazards: Evidence for effects on child health. J Toxicol Environ Health B Crit Rev 10:3-39
2. Rogers J.M. 2008 Tobacco and pregnancy: Overview of exposures and effects. Birth Defects Res C Embryo Today 84:1-15 (Pubitemid 351499890)
3. Tappin D.M., MacAskill S., Bauld L., Eadie D., Shipton D., Galbraith L. 2010 Smoking prevalence and smoking cessation services for pregnant women in Scotland. Subst Abuse Treat Prev Policy 5:1
4. Weinberg C.R., Wilcox A.J., Baird D.D. 1989 Reduced fecundability in women with prenatal exposure to cigarette smoking. Am J Epidemiol 129:1072-1078 (Pubitemid 19123944)
5. Montgomery S.M., Ekbom A. 2002 Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. BMJ 324:26-27 (Pubitemid 34048849)
6. Oken E., Levitan E.B., Gillman M.W. 2008 Maternal smoking during pregnancy and child overweight: Systematic review and meta-analysis. Int J Obes (Lond) 32:201-210 (Pubitemid 351271794)
7. Hylkema M.N., Blacquière M.J. 2009 Intrauterine effects of maternal smoking on sensitization, asthma, and chronic obstructive pulmonary disease. Proc Am Thorac Soc 6:660-662
8. Cornelius M.D., Day N.L. 2009 Developmental consequences of prenatal tobacco exposure. Curr Opin Neurol 22:121-125
9. Ring J.A., Ghabrial H., Ching M.S., Smallwood R.A., Morgan D.J. 1999 Fetal hepatic drug elimination. Pharmacol Ther 84:429-445
10. Krauer B., Dayer P. 1991 Fetal drug metabolism and its possible clinical implications. Clin Pharmacokinet 21:70-80
11. Koukouritaki S.B., Simpson P., Yeung C.K., Rettie A.E., Hines R.N. 2002 Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr Res 51:236-243 (Pubitemid 34101340)
12. Stevens J.C., Hines R.N., Gu C., Koukouritaki S.B., Manro J.R., Tandler P.J., Zaya M.J. 2003 Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307:573-582 (Pubitemid 37310671)
13. Garland M., Abildskov K.M., Kiu T.W., Daniel S.S., Stark R.I. 2005 The contribution of fetal metabolism to the disposition of morphine. Drug Metab Dispos 33:68-76 (Pubitemid 40023516)
14. Hines R.N. 2008 The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118:250-267
15. O'Shaughnessy P.J., Baker P.J., Monteiro A., Cassie S., Bhattacharya S., Fowler P.A. 2007 Developmental changes in human fetal testicular cell numbers and messenger ribonucleic acid levels during the second trimester. J Clin Endocrinol Metab 92:4792-4801 (Pubitemid 350223462)
16. Fowler P.A., Cassie S., Rhind S.M., Brewer M.J., Collinson J.M., Lea R.G., Baker P.J., Bhattacharya S., O'Shaughnessy P.J. 2008 Maternal smoking during pregnancy specifically reduces human fetal desert hedgehog gene expression during testis development. J Clin Endocrinol Metab 93:619-626 (Pubitemid 351240839)
17. Fowler P.A., Bhattacharya S., Gromoll J., Monteiro A., O'Shaughnessy P.J. 2009 Maternal smoking and developmental changes in luteinizing hormone (LH) and the LH receptor in the fetal testis. J Clin Endocrinol Metab 94:4688-4695
18. O'Shaughnessy P.J., Willerton L., Baker P.J. 2002 Changes in Leydig cell gene expression during development in the mouse. Biol Reprod 66:966-975 (Pubitemid 34263116)
19. Baker P.J., O'Shaughnessy P.J. 2001 Expression of prostaglandin D synthetase during development in the mouse testis. Reproduction 122:553-559 (Pubitemid 32975962)
20. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
21. Andersen C.L., Jensen J.L., Ørntoft T.F. 2004 Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245-5250 (Pubitemid 39006544)
22. Fowler P.A., Flannigan S., Mathers A., Gillanders K., Lea R.G., Wood M.J., Maheshwari A., Bhattacharya S., Collie-Duguid E.S., Baker P.J., Monteiro A., O'Shaughnessy P.J. 2009 Gene expression analysis of human fetal ovarian primordial follicle formation. J Clin Endocrinol Metab 94:1427-1435
23. Waxman D.J., Holloway M.G. 2009 Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 76:215-228
24. Stubbs A.P., Engelman J.L., Walker J.I., Faik P., Murphy G.M., Wilkinson M.L. 1994 Measurement of androgen receptor expression in adult liver, fetal liver, and Hep-G2 cells by the polymerase chain reaction. Gut 35:683-686 (Pubitemid 24163799)
25. Kwong W.Y., Wild A.E., Roberts P., Willis A.C., Fleming T.P. 2000 Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development 127:4195-4202
26. Lange I.G., Daxenberger A., Meyer H.H., Rajpert-De Meyts E., Skakkebaek N.E., Veeramachaneni D.N. 2002 Quantitative assessment of foetal exposure to trenbolone acetate, zeranol and melengestrol acetate, following maternal dosing in rabbits. Xenobiotica 32:641-651 (Pubitemid 34984964)
27. O'Regan D., Kenyon C.J., Seckl J.R., Holmes M.C. 2004 Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology. Am J Physiol Endocrinol Metab 287:E863-E870 (Pubitemid 39382921)
28. Kwong W.Y., Miller D.J., Wilkins A.P., Dear M.S., Wright J.N., Osmond C., Zhang J., Fleming T.P. 2007 Maternal low protein diet restricted to the preimplantation period induces a gender-specific change on hepatic gene expression in rat fetuses. Mol Reprod Dev 74:48-56 (Pubitemid 44846356)
29. Bahado-Singh R.O., Schenone M., Cordoba M., Shieh W.S., Maulik D., Kruger M., Reece E.A. 2011 Male gender significantly increases risk of oxidative stress related congenital anomalies in the non-diabetic population. J Matern Fetal Neonatal Med 24:687-691
30. Köhle C., Bock K.W. 2007 Coordinate regulation of phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem Pharmacol 73:1853-1862 (Pubitemid 46677898)
31. Waxman D.J. 1999 P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys 369:11-23 (Pubitemid 29434534)
32. McLemore T.L., Adelberg S., Czerwinski M., Hubbard W.C., Yu S.J., Storeng R., Wood T.G., Hines R.N., Boyd M.R. 1989 Altered regulation of the cytochrome P4501A1 gene: Novel inducer-independent gene expression in pulmonary carcinoma cell lines. J Natl Cancer Inst 81:1787-1794 (Pubitemid 20001422)
33. Thum T., Erpenbeck V.J., Moeller J., Hohlfeld J.M., Krug N., Borlak J. 2006 Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ Health Perspect 114:1655-1661 (Pubitemid 44718269)
34. Baker J.R., Satarug S., Reilly P.E., Edwards R.J., Ariyoshi N., Kamataki T., Moore M.R., Williams D.J. 2001 Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples. Biochem Pharmacol 62:713-721 (Pubitemid 32816988)
35. Rasmussen B.B., Brix T.H., Kyvik K.O., Brøsen K. 2002 The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 12:473-478 (Pubitemid 34913530)
36. Chang T.K., Chen J., Pillay V., Ho J.Y., Bandiera S.M. 2003 Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver. Toxicol Sci 71:11-19 (Pubitemid 36163701)
37. Edwards R.J., Adams D.A., Watts P.S., Davies D.S., Boobis A.R. 1998 Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans. Biochem Pharmacol 56:377-387 (Pubitemid 28473214)
38. Roberts-Thomson S.J., McManus M.E., Tukey R.H., Gonzalez F.F., Holder G.M. 1993 The catalytic activity of four expressed human cytochrome P450s towards benzo[a]pyrene and the isomers of its proximate carcinogen. Biochem Biophys Res Commun 192:1373-1379 (Pubitemid 23218564)
39. Shou M., Korzekwa K.R., Crespi C.L., Gonzalez F.J., Gelboin H.V. 1994 The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo-[a]pyrene trans-7,8-dihydrodiol. Mol Carcinog 10:159-168 (Pubitemid 24257511)
40. Vyhlidal C.A., Gaedigk R., Leeder J.S. 2006 Nuclear receptor expression in fetal and pediatric liver: Correlation with CYP3A expression. Drug Metab Dispos 34:131-137 (Pubitemid 43042654)
41. Lacroix D., Sonnier M., Moncion A., Cheron G., Cresteil T. 1997 Expression of CYP3A in the human liver-evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247:625-634 (Pubitemid 27308642)
42. Cooper C., Javaid K., Westlake S., Harvey N., Dennison E. 2005 Developmental origins of osteoporotic fracture: The role of maternal vitamin D insufficiency. J Nutr 135:2728S-2734S (Pubitemid 43156622)
43. Díaz-Gómez N.M., Mendoza C., González- González N.L., Barroso F., Jiménez-Sosa A., Domenech E., Clemente I., Barrios Y., Moya M. 2007 Maternal smoking and the vitamin D-parathyroid hormone system during the perinatal period. J Pediatr 151:618-623 (Pubitemid 350116127)
44. Cheng J.B., Motola D.L., Mangelsdorf D.J., Russell D.W. 2003 De-orphanization of cytochrome P450 2R1: A microsomal vitamin D 25-hydroxilase. J Biol Chem 278:38084-38093 (Pubitemid 37175340)
45. Schuster I. 2011 Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 1814:186-199
46. Javaid M.K., Crozier S.R., Harvey N.C., Gale C.R., Dennison E.M., Boucher B.J., Arden N.K., Godfrey K.M., Cooper C. 2006 Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: A longitudinal study. Lancet 367:36-43 (Pubitemid 43038668)
47. Pushparajah D.S., Umachandran M., Plant K.E., Plant N., Ioannides C. 2008 Up-regulation of the glutathione S-transferase system in human liver by polycyclic aromatic hydrocarbons; comparison with rat liver and lung. Mutagenesis 23:299-308 (Pubitemid 351918961)
48. Pushparajah D.S., Umachandran M., Plant K.E., Plant N., Ioannides C. 2008 Differential response of human and rat epoxide hydrolase to polycyclic aromatic hydrocarbon exposure: Studies using precision-cut tissue slices. Mutat Res 640:153-161
49. Burchiel S.W., Thompson T.A., Lauer F.T., Oprea T.I. 2007 Activation of dioxin response element (DRE)-associated genes by benzo (a) pyrene 3,6-quinone and benzo (a) pyrene 1,6-quinone in MCF-10A human mammary epithelial cells. Toxicol Appl Pharmacol 221:203-214 (Pubitemid 46764801)
50. Pickett G., Seagrave J., Boggs S., Polzin G., Richter P., Tesfaigzi Y. 2010 Effects of 10 cigarette smoke condensates on primary human airway epithelial cells by comparative gene and cytokine expression studies. Toxicol Sci 114:79-89
51. Williams E.S., Panko J., Paustenbach D.J. 2009 The European Union's REACH regulation: A review of its history and requirements. Crit Rev Toxicol 39:553-575
52. Juchau M.R., Chao S.T., Omiecinski C.J. 1980 Drug metabolism by the human fetus. Clin Pharmacokinet 5:320-339 (Pubitemid 10026851)
53. Pelkonen O. 1980 Biotransformation of xenobiotics in the fetus. Pharmacol Ther 10:261-281
54. Klinger W. 2005 Developmental pharmacology and toxicology: Biotransformation of drugs and other xenobiotics during postnatal development. Eur J Drug Metab Pharmacokinet 30:3-17 (Pubitemid 40910760)
55. Cooper R.L. 2009 Current developments in reproductive toxicity testing of pesticides. Reprod Toxicol 28:180-187